kwuny <@t> email.cs.nsw.gov.au
Wed Jun 21 19:33:42 CDT 2006
I would like to make a point about the antibody you are using which is
Zymed's MLH-1 (clone 14).
As you know, MLH1 antibody is one of the most important colon cancer
markers. It is particularly useful in determining microsatellite instability
(MSI) status and tumors arising in patients with hereditary non-polyposis
colorectal cancer (HNPCC) syndrome.
MLH1 is notorious for its capricious staining manner in some cases and I
tried several MLH1 antibodies on the market before I decided to use BD
Pharmingen's (clone G168-15) for last 5 years. Occasionally I still had some
problem with the stain so I decided to try Zymed's MLH1 (clone 14) last
year. The staining was sometimes stronger than our routine BD's MLH1 so I
decided to use Zymed's MLH1 (clone 14) as our routine one during the year
2005. With the help of some new and more sensitive detection system recently
(two step polymer instead of one step), I was able to produce good stains
for MSI test. Our panel also includes MHS2, MSH6, PMS2 and MGMT. It is well
known that MLH1 delete and PMS2 delete are occurring together and it is very
rare for a case showing only PMS2 negative. During the last year, we had
several cases of colon cancer which appeared to be PMS2 delete only. I had
to repeat MLH1 stains to confirm the result in some cases.
When I compared the two MLH1 clones separately, the result was so dramatic.
Our old clone (BD Pharmingen G168-15) showed a clean MLH1 delete in tumour
cells only, whereas clone 14 MLH1 showed a strong positive staining in the
tumour cells as well. Both clones showed a strong positivity in the normal
epithelial cells. Clone 14 MLH1 clearly demonstrated false positive
Therefore I had to stop using the clone14 MLH1 immediately. I used 1/100
dilution and if I dilute 1/300 or 1/500 the normal epithelium would not
stain. I also tried different Lot number and again showed false positivity.
So I had to repeat all the colon carcinoma cases during the year 2005 and
found that many MLH1 (and PMS2) delete cases were reported incorrectly. In
fact I would like to know that whether you've ever seen a delete case with
the clone 14 MLH1.
These results were also confirmed by MSI molecular biological test at St.
Vincent Hospital here in Sydney.
PS: We are now using BondMax autostainer for MSI test and I don't need to
incubate overnight anymore. The staining is fantastic!
Senior Hospital Scientist
Dept of Anatomical Pathology
Concord NSW 2139
Email:kwuny <@t> email.cs.nsw.gov.au
From: histonet-bounces <@t> lists.utsouthwestern.edu
[mailto:histonet-bounces <@t> lists.utsouthwestern.edu] On Behalf Of Mary Judd
Sent: Wednesday, 21 June 2006 8:31 PM
To: histonet <@t> lists.utsouthwestern.edu
Subject: [Histonet] MLH-1
We use MLH-1(14) from Zymed cat.no. 18-2342
We pressure cook in citrate buffer 6pH, use the antibody at 1:30 and
incubate overnight at 4C.
Section Head Immunohistochemistry
Level E, Mailpoint 2
Southampton University Hospitals Trust
Tel. 02380 795144
Fax. 02380 796869
D I S C L A I M E R
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. Any views or opinions presented are solely those of
the author and do not necessarily represent those of the
Trust unless explicitly stated otherwise. If you have received this
e-mail in error please delete the e-mail and contact the
Southampton University Hospitals NHS Trust Helpdesk on:-
The information contained in this e-mail may be subject to public
disclosure under the Freedom of Information Act 2000. Unless the
Information is legally exempt from disclosure, the confidentiality
of this e-mail and your reply cannot be guaranteed.
This footnote also confirms that this email message has been swept
by MailMarshal for the presence of computer viruses.
Please visit our website at http://www.suht.nhs.uk
Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu
This email has been scanned for the Sydney South West Area Health Service by
the MessageLabs Email Security System. SSWAHS regularly monitors emails and
attachments to ensure compliance with the NSW Government's Electronic
"This message is intended for the addressee named and may contain confidential information. If you are not the intended recipient, please destroy it and notify the sender. Views expressed in this message are those of the individual sender, and are not necessarily the views of the Sydney South West Area Health Service."
More information about the Histonet